Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.98%
1,051.76
+10.23
+0.98%
—1,041.531,039.461,055.221,038.51——
SIXC
Communications
SIXC
Communications
SIXC
-0.27%
603.63
-1.63
-0.27%
—605.26605.26605.49600.17——
SIXE
Energy
SIXE
Energy
SIXE
-1.64%
1,261.69
-21.05
-1.64%
—1,282.741,281.591,291.361,260.30——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.15%
1,719.74
+19.47
+1.15%
—1,700.271,701.571,724.931,697.55——
SIXM
Financials
SIXM
Financials
SIXM
+0.73%
633.88
+4.57
+0.73%
—629.31629.49635.69625.53——
SIXR
Staples
SIXR
Staples
SIXR
-0.39%
864.41
-3.42
-0.39%
—867.83866.53866.53855.21——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.65%
216.98
+1.41
+0.65%
—215.57215.57217.65215.40——
SIXT
Technology
SIXT
Technology
SIXT
+1.84%
3,552.18
+64.31
+1.84%
—3,487.873,514.713,567.893,502.97——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.30%
898.38
+2.66
+0.30%
—895.72899.33905.79898.38——
SIXV
Health care
SIXV
Health care
SIXV
-0.42%
1,480.16
-6.31
-0.42%
—1,486.471,487.361,493.601,480.12——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.89%
2,367.43
+43.86
+1.89%
—2,323.572,327.882,371.052,319.59——
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$0.50
-1.61%
(-0.0082) 1D
May 20, 11:30:21 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SCNI...
Open
$0.51
High
$0.52
Low
$0.44
Mkt. cap
1.97M
Avg. vol.
6.91M
Volume
792.02K
52-wk high
$6.18
52-wk low
$0.44
EPS
-$3.56
Beta
2.19
Shares outstanding
3.54M
No. of employees
45
News stories
From sources across the web
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR
CEO-
Employees45
FoundedJan 1, 2003
Headquarters-
SectorBiotechnology
Websitescinai.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
386.50K
386.50K
269.00K
269.00K
Cost of goods sold
1.02M
1.02M
960.00K
960.00K
Cost of revenue
1.02M
1.02M
960.00K
960.00K
Research and development expenses
618.50K
618.50K
566.00K
566.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
628.00K
628.00K
632.50K
632.50K
Operating expense
1.25M
1.25M
1.20M
1.20M
Total operating expenses
2.27M
2.27M
2.16M
2.16M
Operating income
-1.88M
-1.88M
-1.89M
-1.89M
Other non operating income
-
-
-3.50K
-3.50K
EBT including unusual items
-2.07M
-2.07M
-2.09M
-2.09M
EBT excluding unusual items
-2.07M
-2.07M
-2.09M
-2.09M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.07M
-2.07M
-2.09M
-2.09M
Net profit margin
-534.80%
-534.80%
-775.65%
-775.65%
Earnings per share
-
-
-
-
Interest and investment income
-
-
16.00K
16.00K
Interest expense
-185.50K
-185.50K
-
-
Net interest expenses
-185.50K
-185.50K
16.00K
16.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.53M
-1.53M
-1.53M
-1.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer